Retrospective 1,395 vaccinated COVID-19 cases, showing significantly lower hospitalization and oxygen supplementation with monoclonal antibody treatment, primarily casirivimab-imdevimab. Hospitalization was significantly associated with comorbidities.
|
|
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. |
This study is excluded:
patients were treated with different medications, results specific to each medication were not reported.
Conflicts of interest:
research funding from the drug patent holder.

Bierle et al., 10/20/2021, retrospective, USA, North America, peer-reviewed, 7 authors.
Contact:
[email protected].